Edition:
United States

CanBas Co Ltd (4575.T)

4575.T on Tokyo Stock Exchange

720JPY
22 Nov 2017
Change (% chg)

¥48 (+7.14%)
Prev Close
¥672
Open
¥686
Day's High
¥744
Day's Low
¥686
Volume
134,000
Avg. Vol
26,233
52-wk High
¥950
52-wk Low
¥595

Chart for

About

CanBas Co., Ltd. is a company engaged in the research and development of anticancer drugs which have little influence to the normal cells. In the general medicinal products development process, the Company is engaged in the exploration of compounds in accordance with the medicinal products subjects; the improvement of the... (more)
No analyst recommendations are available for .

Overall

Beta: 3.32
Market Cap(Mil.): ¥3,960.79
Shares Outstanding(Mil.): 5.50
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.51 15.54
EPS (TTM): -- -- --
ROI: -- 15.16 11.80
ROE: -- 16.57 15.75

BRIEF-CanBas announces exercise of options

* Says 4,590 units of its 10th series options were exercised to 459,000 shares of its common stock on June 27, with exercised price of 812 yen per share

Jun 27 2017

BRIEF- CanBas signs joint research agreement with FUJIFILM

* Says it signed a joint research agreement with FUJIFILM Corporation, regarding an anticancer drug using peptide, on June 26

Jun 26 2017

Earnings vs. Estimates